This site is intended for healthcare professionals only
LoginRegister
No Promotional Campaigns for GLP-1 Obesity Drugs: CDSCO Cautions Pharma FirmsOnly Licensed Importers Can Overprint Labels Under Rule 104A, Clarifies CDSCO
Jayeeta Chatterjee joins Sandoz as Head - HCM TransformationSandoz: Jayeeta Chatterjee appointed as Head - HCM Transformation
Aurobindo Pharma Delays 26% Stake Buy in Swarnaakshu Solar Over Pending ApprovalsAurobindo Pharma arm Curateq Biologics incorporates new wholly owned subsidiary in Netherlands
CDSCO Panel Directs Abbott to Incorporate New Safety, Follow-up Measures in Clarithromycin StudyUSFDA approves Abbott Tendyne to replace mitral valve without open-heart surgery
AstraZeneca Saphnelo subcutaneous self-administration recommended for approval in EU by CHMP for systemic lupus erythematosusAstraZeneca Imfinzi recommended for approval in EU for adults with muscle-invasive bladder cancer
Eli Lilly to Ink USD 2 Billion AI Drug Deal with Insilico for GLP-1 Diabetes TherapyEli Lilly to acquire SiteOne Therapeutics in USD 1 billion deal
Anar Modi named CHO at Senores PharmaAnar Modi named CHO at Senores Pharma
USFDA Approves Corcept Therapeutics Ovarian Cancer Drug LifyorliBayer Sevabertinib gets USFDA Priority Review status for HER2-mutant non-small cell lung cancer
USFDA updates Camzyos label to reduce echocardiography monitoring requirements, contraindications: Bristol Myers SquibbBristol Myers Squibb bags European Commission nod for Subcutaneous formulation of Opdivo across...
Ipca Pharma incorporates new wholly owned arm in Federal Republic of GermanyExpert Panel Tells IPCA to Revise Hydroxychloroquine Phase III Trial for Diabetes
Natco PharmaNatco Pharma announces key leadership appointments across quality, operations, regulatory,...
Intas Pharma appoints Amit Modi as Associate Vice President - Supply Chain Management.Intas Pharma appoints Amit Modi as Associate Vice President - Supply Chain Management.
X